IQCK antisense RNA 1 (IQCK-AS1)

IQCK antisense RNA 1 (IQCK-AS1), also referred to as CTD-2380F24.1, is a predicted long non-coding antisense RNA transcribed opposite the IQCK gene locus. As of September 2025, there is no peer-reviewed literature or curated database entry establishing IQCK-AS1 as a functional molecule or disease-relevant target. It is not documented as a receptor, enzyme, transporter, or other therapeutic target protein. Its classification is best described as “long non-coding antisense RNA,” and there is no evidence linking it to biological functions, disease relevance, or drug interactions. Some confusion may exist due to similarly named, functionally studied molecules (e.g., IQCJ-SCHIP1-AS1), but these are not identical and should not be conflated[1][3][5]. It is possible that IQCK-AS1 is a predicted, uncharacterized transcript with no current therapeutic or biomarker utility. Note: If you intended a different gene or transcript, or if your query referred to IQCJ-SCHIP1-AS1 (a functionally validated lncRNA in colorectal cancer[1]), please clarify for further detailed information.

Other names

CTD-2380F24.1IQCK-AS1